88IV - PR Newswire Asia's news - Health Care/Hospital


GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million TAIPEI and SAN DIEGO , July 15, 2026 /PRNewswire/ -- GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis HANGZHOU, China and SHANGHAI and BOSTON , July 15, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process NEWARK, Del. , July 15, 2026 /PRNewswire/ -- Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 藥機審長發第47號) ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction BGE-102, a potent, structurally novel, orally available, brain-penetrant small molecule NLRP3 inhibitor developed from a hit identified via HitGen's DEL technology platform, has advanced into a Phase 2 ... 2026-07-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging - Development of next-generation denoising image processing technology 'SHINE' completed; full-scale commercialization now underway ... 2026-07-14T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Samyang Corporation Unveils New Crystalline Dietary Fiber Brand 'Fibernova' at IFT 2026 Participates in IFT 2026, the international food technology expo held in Chicago, U.S., from July 13 to 15 Names its crystalline dietary fiber brand "Fibernova," signifying an innovative ... 2026-07-14T Food/Beverages Health Care/Hospital Trade show news
VARON Expands Pet Oxygen Solutions with New Portable Oxygen Bundle and Pet Oxygen Mask LOS ANGELES , July 14, 2026 /PRNewswire/ -- As more pet owners look for ways to support their pets' comfort and breathing needs beyond the veterinary clinic, VARON continues to expand its pet oxygen ... 2026-07-14T Computer/Electronics Health Care/Hospital Household/Consumer/Cosmetics
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer HONG KONG , July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer ... 2026-07-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital